Catch It Early, Cure It Completely

Early Detection, Biopsy & mHealth Screening

Led by GCP-Certified Researcher Dr. Manish Tiwari. We utilize advanced clinical screening, precision biopsies, and innovative mHealth technology to diagnose oral premalignant and malignant lesions at their most treatable stage.

Dr Manish Tiwari Clinical Researcher

Leukoplakia

Thick, white patches on the gums, insides of cheeks, or bottom of the mouth that cannot be scraped off.

Erythroplakia

Flat or slightly raised, red areas in the mouth that bleed easily when scraped.

OSMF

Oral Submucous Fibrosis, characterized by severe stiffness and restricted mouth opening (common in tobacco/gutka users).

Non-Healing Ulcers

Any mouth sore or ulcer that persists for more than 3 weeks without healing.

Clinical Leadership

Pioneering mHealth & Diagnostics

Dr. Tiwari merges deep surgical expertise with active clinical research. His work focuses on bringing advanced diagnostics to both urban clinics and high-risk populations.

Precision Biopsy Techniques

A biopsy is the only definitive way to diagnose oral cancer. We utilize minimally invasive techniques to extract tissue samples from suspicious lesions with extreme accuracy.

  • Incisional Biopsy: Small sample taken from the tumor edge.
  • Excisional Biopsy: Complete removal of small premalignant lesions.
  • Fast, accurate histopathology coordination.

mHealth Screening Initiatives

As a GCP-certified clinical researcher, Dr. Tiwari has led major BIOCON-sponsored mHealth (Mobile Health) screening studies comparing digital screening methods against conventional detection in high-risk populations.

  • Leveraging technology for early mucosal screening.
  • Published research on premalignant lesion prevalence.
  • Bridging the gap in delayed cancer diagnoses.
The Protocol

From Screening to Staging

If you notice a warning sign, our clinical pathway is designed to give you rapid, definitive answers.

01

Clinical Evaluation

A thorough physical examination of the oral cavity, neck nodes, and medical history review to assess the risk of the lesion.

02

Tissue Biopsy

Performed swiftly under local anesthesia in the clinic. The sample is sent to specialized oncopathologists.

03

Radiological Staging

If the biopsy confirms malignancy, we immediately proceed with MRI, CT, or PET scans to determine the exact stage and spread.

Clinical Evaluation and Biopsy

Evidence-Based Practice

Why Early Detection Matters

Cancers caught in Stage I or II have drastically higher survival rates and require far less extensive surgery and reconstruction.

  • Higher Cure Rates: Up to 90% in early stages.
  • Simpler Surgeries: Avoiding major jaw or tongue removal.
  • Less Need for Chemo/Radiation: Reducing long-term side effects.

Published Academic Focus

Dr. Tiwari's clinical research actively drives better early detection protocols across India.

  • OSMF Guidelines: Contributor to major textbooks on Oral Submucous Fibrosis.
  • Premalignant Lesions: Published studies on tobacco cessation and lesion prevalence.
  • GCP Certified: Maintaining the highest global standards in clinical trials.